Related Experiment Video
Updated: Jun 8, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
PP2A interaction with Rb2/p130 mediates translocation of Rb2/p130 into the nucleus in all-trans retinoic acid-treated
Enkhtsetseg Purev1, Dianne R Soprano, Kenneth J Soprano
1Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.
Abstract:
One of the mechanisms by which all-trans retinoic acid (ATRA) has been shown to suppress the growth of CAOV3 ovarian carcinoma cells involves an increase in the accumulation of Rb2/p130 protein, a member of the retinoblastoma family of tumor suppressors. This increase in accumulation of RB2/p130 by ATRA results from increased stability of Rb2/p130 protein as a result of an increase in dephosphorylation of the protein by the serine/threonine phosphatase PP2A. We show that upon ATRA treatment, PP2A interacts with the Rb2/p130 C-terminus and specifically dephosphorylates two residues (S1080 and T1097) adjacent to NLS1 and NLS2 of Rb2/p130. Moreover, co-immunoprecipitation studies reveal that Rb2/p130 can form a complex with the nuclear transport proteins, importin α and importin β, binding to the same dephosphorylated NLS1 and NLS2 sites. Finally, mutation of S1080 and T1097 results in retension of Rb2/p130 in the cytoplasm. Our studies suggest that one mechanism by which ATRA treatment of CAOV3 cells induces G0/G1 arrest involves the recruitment of PP2A to the C-terminus of Rb2/p130, resulting in the dephosphorylation of the S1080 and T1097 adjacent to the NLS and the subsequent interaction of Rb2/p130 with importins leading to transport of the Rb2/p130 to the nucleus where it inhibits cell-cycle progression.
Insights
All-trans retinoic acid (ATRA) suppresses ovarian cancer growth by stabilizing Rb2/p130 protein. This involves PP2A phosphatase dephosphorylating Rb2/p130, enabling nuclear transport and cell-cycle arrest.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- All-trans retinoic acid (ATRA) is known to inhibit the growth of CAOV3 ovarian carcinoma cells.
- Rb2/p130, a tumor suppressor protein, is implicated in this growth suppression.
- The precise molecular mechanisms underlying ATRA's effect on Rb2/p130 accumulation require further elucidation.
Purpose of the Study:
- To investigate the mechanism by which ATRA increases Rb2/p130 protein accumulation in CAOV3 cells.
- To identify the specific interactions and modifications of Rb2/p130 involved in ATRA-mediated cell-cycle arrest.
- To explore the role of protein phosphatase 2A (PP2A) in regulating Rb2/p130 stability and function.
Main Methods:
- Treatment of CAOV3 cells with ATRA.
- Western blotting to assess protein levels and phosphorylation status.
- Co-immunoprecipitation to study protein-protein interactions.
- Site-directed mutagenesis to investigate the role of specific residues.
- Analysis of protein localization using immunofluorescence.
Main Results:
- ATRA treatment increases Rb2/p130 protein stability through dephosphorylation mediated by PP2A.
- PP2A directly interacts with the C-terminus of Rb2/p130, dephosphorylating S1080 and T1097 residues near nuclear localization signals (NLS).
- Dephosphorylated Rb2/p130 binds to importin α and importin β, facilitating nuclear transport.
- Mutating S1080 and T1097 prevents nuclear localization of Rb2/p130, causing cytoplasmic retention.
Conclusions:
- ATRA induces G0/G1 cell-cycle arrest in CAOV3 cells by recruiting PP2A to Rb2/p130.
- This interaction leads to dephosphorylation of key residues, promoting Rb2/p130 nuclear import via importins.
- Nuclear Rb2/p130 then inhibits cell-cycle progression, contributing to ATRA's anti-cancer effects.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway

